Cargando…
The 46.1 Antibody Mediates Neurotensin Uptake into the CNS and the Effects Depend on the Route of Intravenous Administration
Central nervous system (CNS) exposure to blood-borne biotherapeutics is limited by the restrictive nature of the brain vasculature. In particular, tightly sealed endothelial cells of the blood–brain barrier (BBB) prevent the uptake of protein and gene medicines. An approach to increase the bioavaila...
Autores principales: | Georgieva, Julia V., Katt, Moriah, Ye, Zhou, Umlauf, Benjamin J., Wenthur, Cody J., Shusta, Eric V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414616/ https://www.ncbi.nlm.nih.gov/pubmed/36015332 http://dx.doi.org/10.3390/pharmaceutics14081706 |
Ejemplares similares
-
Endogenous CNS Expression of Neurotensin and Neurotensin Receptors Is Altered during the Postpartum Period in Outbred Mice
por: Driessen, Terri M., et al.
Publicado: (2014) -
46.1 Barriers and Innovations to Delivering Crisis Intervention Services Before and During COVID-19 in California
por: O'Malley, Corey, et al.
Publicado: (2021) -
Identification of lamprey variable lymphocyte receptors that target the brain vasculature
por: Lajoie, Jason M., et al.
Publicado: (2022) -
Poster Sessions 323-461
Publicado: (2002) -
PM461. Inflammation in schizophrenia: Imaging genetics
por: Hwang, Wu Jeong, et al.
Publicado: (2016)